Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

Clinical trials in chronic inflammatory demyelinating polyneuropathy (CIDP) often assess efficacy using the ordinal Inflammatory Neuropathy Cause and Treatment (INCAT) disability score. Here, data from the PATH study was reanalyzed using change in Inflammatory Rasch‐built Overall Disability Scale (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Merkies, Ingemar S. J., van Schaik, Ivo N., Bril, Vera, Hartung, Hans‐Peter, Lewis, Richard A., Sobue, Gen, Lawo, John‐Philip, Mielke, Orell, Cornblath, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310622/
https://www.ncbi.nlm.nih.gov/pubmed/35266243
http://dx.doi.org/10.1111/jns.12487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310622/
https://www.ncbi.nlm.nih.gov/pubmed/35266243
http://dx.doi.org/10.1111/jns.12487

Ejemplares similares